Literature DB >> 16373636

Stroke and encephalopathy after cardiac surgery: an update.

Guy M McKhann1, Maura A Grega, Louis M Borowicz, William A Baumgartner, Ola A Selnes.   

Abstract

BACKGROUND AND
PURPOSE: As a result of advances in surgical, anesthetic, and medical management, cardiac surgery can now be performed on older, sicker patients, some of whom have had prior cardiac interventions. As surgical mortality has declined in recent years, attention has focused on the complications of stroke and encephalopathy after cardiac surgery. SUMMARY OF REVIEW: Patients with preexisting cerebrovascular disease are at increased risk for these untoward neurological outcomes, which are associated with longer lengths of hospital stay, higher costs, and greater mortality. The mechanisms underlying these neurological events may include microemboli and hypoperfusion during surgery, and postoperative atrial fibrillation. Predictive models, based on information available before surgery, allow identification of these "high risk" patients.
CONCLUSIONS: Establishing the degree of functionally significant vascular disease of the brain before surgery should be an essential part of the preoperative evaluation, particularly when modifications in surgical technique or novel neuroprotective agents are being evaluated.

Entities:  

Mesh:

Year:  2005        PMID: 16373636     DOI: 10.1161/01.STR.0000199032.78782.6c

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  77 in total

1.  Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model.

Authors:  William C Culp; Sean D Woods; Robert D Skinner; Aliza T Brown; John D Lowery; Jennifer L H Johnson; Evan C Unger; Leah J Hennings; Michael J Borrelli; Paula K Roberson
Journal:  J Vasc Interv Radiol       Date:  2011-11-12       Impact factor: 3.464

2.  Improved perioperative neurological monitoring of coronary artery bypass graft patients reduces the incidence of postoperative delirium: the Haga Brain Care Strategy.

Authors:  Wijnand A C Palmbergen; Agnes van Sonderen; Ali M Keyhan-Falsafi; Ruud W M Keunen; Ron Wolterbeek
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-09

3.  Microbubble transmission during cardiotomy infusion of a hardshell venous reservoir with integrated cardiotomy versus a softshell venous reservoir with separated cardiotomy: an in vitro comparison.

Authors:  Kieron C Potger; Darryl McMillan; Mark Ambrose
Journal:  J Extra Corpor Technol       Date:  2013-06

Review 4.  Stroke associated with coronary artery bypass grafting.

Authors:  Keiji Oi; Hirokuni Arai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-07-08

Review 5.  Toll-like receptor signaling in endogenous neuroprotection and stroke.

Authors:  B J Marsh; R L Williams-Karnesky; M P Stenzel-Poore
Journal:  Neuroscience       Date:  2008-08-12       Impact factor: 3.590

6.  [Cognitive deterioration after cardiosurgery].

Authors:  N Schwarz; M Schönburg; S Kastaun; T Gerriets; M Kaps
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

7.  Strokes after cardiac surgery: mostly right hemispheric ischemic with mild residual damage.

Authors:  I Korn-Lubetzki; A Oren; E Asher; M Dano; D Bitran; D Fink; B Steiner-Birmanns
Journal:  J Neurol       Date:  2007-11-09       Impact factor: 4.849

8.  Statin use and neurologic morbidity after coronary artery bypass grafting: A cohort study.

Authors:  M A Koenig; M A Grega; M M Bailey; L D Pham; S L Zeger; W A Baumgartner; G M McKhann
Journal:  Neurology       Date:  2009-11-11       Impact factor: 9.910

9.  Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant.

Authors:  Rebecca L Williams-Karnesky; Mary P Stenzel-Poore
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  Anemia and red blood cell transfusion in neurocritical care.

Authors:  Andreas H Kramer; David A Zygun
Journal:  Crit Care       Date:  2009-06-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.